Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Medigene AG

< Previous 1 2 Next >
News headline image
Medigene Files Patent for Unique NK-Specific TCR Construct with European Patent Office
From Medigene AG
Via GlobeNewswire
News headline image
Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers
From Medigene AG
Via GlobeNewswire
News headline image
Medigene AG Expands Patent Portfolio with Patent Grant for its JOVI Technology in the U.S.
From Medigene AG
Via GlobeNewswire
News headline image
Medigene AG announces closing of its first SEPA tranche
From Medigene AG
Via GlobeNewswire
News headline image
Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers
From Medigene AG
Via GlobeNewswire
News headline image
Medigene Receives Milestone Payment from Regeneron Pharmaceuticals, Inc.
From Medigene AG
Via GlobeNewswire
News headline image
Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment
From Medigene AG
Via GlobeNewswire
News headline image
Medigene Presents Data on an Innovative IFN-γ Biosensor Technology at SITC 2024
From Medigene AG
Via GlobeNewswire
News headline image
Medigene Presents Latest Data on UniTope & TraCR Technology at PEGS and SITC 2024
From Medigene AG
Via GlobeNewswire
News headline image
Medigene Presents Unique Approach for Use of Optimal T Cell Receptors in TCR-Guided Modalities at Cell 2024
From Medigene AG
Via GlobeNewswire
News headline image
Medigene to Present at Upcoming Investor Conferences
From Medigene AG
Via GlobeNewswire
News headline image
Medigene presents UniTope and TraCR a universal detection system for 3S recombinant TCRs at ASGCT 2024
From Medigene AG
Via GlobeNewswire
News headline image
Medigene AG reports Financial Results and Business Update for Q3 2024
From Medigene AG
Via GlobeNewswire
News headline image
Medigene to Present at Upcoming Scientific Conferences
From Medigene AG
Via GlobeNewswire
News headline image
Medigene will Present at ASGCT 2024 and Host R&D Event
From Medigene AG
Via GlobeNewswire
News headline image
Medigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021
From Medigene AG
Via GlobeNewswire
News headline image
Medigene to Host Virtual R&D Event on Medigene’s Optimal 3S TCRs for TCR-Guided Precision Immunotherapies
From Medigene AG
Via GlobeNewswire
News headline image
Medigene Presents Progress on KRAS Library and UniTope & TraCR Technology at ESMO 2024
From Medigene AG
Via GlobeNewswire
News headline image
Medigene Announces U.S. FDA Clearance of IND Application for MDG1015, a First-in-Class, Third Generation T Cell Receptor Engineered T Cell (TCR-T) Therapy for Multiple Solid Tumor Indications
From Medigene AG
Via GlobeNewswire
News headline image
Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform
From Medigene AG
Via GlobeNewswire
News headline image
Medigene to Present at Upcoming Investor Conferences
From Medigene AG
Via GlobeNewswire
News headline image
Medigene AG implements announced 2:1 share capital reduction and consolidation of the shares effective August 29, 2024
From Medigene AG
Via GlobeNewswire
News headline image
Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update
From Medigene AG
Via GlobeNewswire
News headline image
Medigene AG to Report Half-Year 2024 Financial Results on August 14, 2024
From Medigene AG
Via GlobeNewswire
News headline image
Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers
From Medigene AG
Via GlobeNewswire
News headline image
Medigene to Present at ESMO Congress 2024
From Medigene AG
Via GlobeNewswire
News headline image
Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China
From Medigene AG
Via GlobeNewswire
News headline image
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
From Medigene AG
Via GlobeNewswire
News headline image
Medigene Reports Results of Annual General Meeting
From Medigene AG
Via GlobeNewswire
News headline image
Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
From Medigene AG
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.